Intellectual Property Law

Access to HIV/AIDS Medicines

By Frank Pasquale

The Campaign for Access to Essential Medicines explains why UNITAID’s efforts to develop a patent pool of HIV/AIDS treatments are so important:

Meanwhile, the US health care finance system appears to be getting into a bit of a standoff with HIV/AIDS drug makers:

Without reliable access to the medications, which cost patients in the AIDS Drug Assistance Program an average of $12,000 a year, people with H.I.V. are more likely to develop full-blown AIDS, transmit the virus and require expensive hospitalizations. Eleven states have closed enrollment in the federal program, most recently Florida, which has the nation?s third-largest population of people with H.I.V.

The need for programs like the Health Impact Fund is more urgent than ever.

No Tags

Full post as published by Madisonian.net on July 11, 2010 (boomark / email).